Manufacture of basic pharmaceutical products
CHIRON PHARMASYNTH AS
Revenue 2024
NOK 26.1m
Operating profit
NOK −722,000
Equity
NOK 18.9m
Incorporated
2001
Share capital
NOK 1.8m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 26.1m | |
| Total operating costs | 26.8m | |
| Operating profit (EBIT) | −722k | |
| Net financial items | 465k | |
| Profit for the year | −258k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 32.0m | |
| of which current assets | 32.0m | |
| Equity | 18.9m | |
| Total liabilities | 13.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.